Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer

OBJECTIVE: Immune checkpoint inhibitors (ICIs) or combined with chemotherapy exhibit substantial efficacy for the treatment of advanced non‐small cell lung cancer (NSCLC). However, reliable biomarkers that can monitor response to first‐line ICIs ± chemotherapy remain unclear. METHODS: A total of 16...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Lei, Gao, Guanghui, Zhao, Chao, Wang, Haowei, Yao, Chao, Yu, Hanchuanzhi, Yao, Jichen, Li, Feng, Guo, Lijie, Jian, Qijie, Chen, Xiaoxia, Li, Xuefei, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358227/
https://www.ncbi.nlm.nih.gov/pubmed/37184093
http://dx.doi.org/10.1002/cam4.6108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358227/
https://www.ncbi.nlm.nih.gov/pubmed/37184093
http://dx.doi.org/10.1002/cam4.6108

Ejemplares similares